Neuropace Inc (NPCE)

$10.79 +0.36 (3.45%)
Market Cap 351.32M
Revenue (ttm) 79.91M
Net Income (ttm) -27.14M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -33.96%
Debt to Equity Ratio 7.43
Volume 173,000
Avg Vol 257,454
Day's Range N/A - N/A
Shares Out 32.56M
Stochastic %K 32%
Beta 2.03
Analysts Strong Sell
Price Target $17.14

Latest News on NPCE

NeuroPace Provides Update on Tariff Status

Apr 14, 2025, 4:05 PM EDT - 5 days ago

NeuroPace Provides Update on Tariff Status

NeuroPace Announces Data From a Long-Term Post-Approval Study of the RNS System in Focal Epilepsy at the 2025 AAN Annual Meeting

Apr 8, 2025, 8:00 AM EDT - 11 days ago

NeuroPace Announces Data From a Long-Term Post-Approval Study of the RNS System in Focal Epilepsy at the 2025 AAN Annual Meeting

NeuroPace Announces Upcoming Oral Presentation of Data from the Long-Term Post-Approval Study of the RNS System at the 2025 AAN Annual Meeting

Apr 3, 2025, 8:00 AM EDT - 16 days ago

NeuroPace Announces Upcoming Oral Presentation of Data from the Long-Term Post-Approval Study of the RNS System at the 2025 AAN Annual Meeting

NeuroPace Announces Refocusing of Product Portfolio

Apr 2, 2025, 4:05 PM EDT - 17 days ago

NeuroPace Announces Refocusing of Product Portfolio

NeuroPace to Present at the 24th Annual Needham Virtual Healthcare Conference

Mar 26, 2025, 8:00 AM EDT - 24 days ago

NeuroPace to Present at the 24th Annual Needham Virtual Healthcare Conference

NeuroPace, Inc. (NPCE) Q4 2024 Earnings Call Transcript

Mar 4, 2025, 7:45 PM EST - 6 weeks ago

NeuroPace, Inc. (NPCE) Q4 2024 Earnings Call Transcript

NeuroPace Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 4, 2025, 4:05 PM EST - 6 weeks ago

NeuroPace Reports Fourth Quarter and Full Year 2024 Financial Results

UPDATE – NeuroPace to Present at the Leerink Partners Global Healthcare Conference

Mar 3, 2025, 9:15 PM EST - 6 weeks ago

UPDATE – NeuroPace to Present at the Leerink Partners Global Healthcare Conference

NeuroPace to Present at the Leerink Partners Global Healthcare Conference

Mar 3, 2025, 4:05 PM EST - 6 weeks ago

NeuroPace to Present at the Leerink Partners Global Healthcare Conference

NeuroPace Completes Repurchase of 5.3 Million Shares of Its Common Stock from KCK Ltd.

Feb 20, 2025, 4:05 PM EST - 2 months ago

NeuroPace Completes Repurchase of 5.3 Million Shares of Its Common Stock from KCK Ltd.

NeuroPace to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025

Feb 19, 2025, 4:05 PM EST - 2 months ago

NeuroPace to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025

NeuroPace Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares

Feb 18, 2025, 4:05 PM EST - 2 months ago

NeuroPace Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares

NeuroPace Announces Pricing of Public Offering of $65 Million of Common Stock

Feb 14, 2025, 6:33 AM EST - 2 months ago

NeuroPace Announces Pricing of Public Offering of $65 Million of Common Stock

NeuroPace Announces Proposed Public Offering of $65 Million of Common Stock

Feb 13, 2025, 4:34 PM EST - 2 months ago

NeuroPace Announces Proposed Public Offering of $65 Million of Common Stock

NeuroPace Announces Upcoming Oral Presentation of Data from the Post-Approval Study of the RNS System at the American Academy of Neurology 2025 Annual Meeting Being Held April 5th – 9th

Feb 3, 2025, 4:05 PM EST - 2 months ago

NeuroPace Announces Upcoming Oral Presentation of Data from the Post-Approval Study of the RNS System at the American Academy of Neurology 2025 Annual Meeting Being Held April 5th – 9th

NeuroPace Issues 2025 Financial Guidance Targets

Jan 28, 2025, 5:15 PM EST - 2 months ago

NeuroPace Issues 2025 Financial Guidance Targets

NeuroPace Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2024 and Provides Business Updates

Jan 8, 2025, 4:05 PM EST - 3 months ago

NeuroPace Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2024 and Provides Business Updates

NeuroPace to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Dec 18, 2024, 4:05 PM EST - 4 months ago

NeuroPace to Present at the 43rd Annual J.P. Morgan Healthcare Conference

NeuroPace to Host Investor Day on January 28th in New York City

Dec 12, 2024, 4:05 PM EST - 4 months ago

NeuroPace to Host Investor Day on January 28th in New York City

NeuroPace to Showcase the RNS System at the 2024 American Epilepsy Society (AES) Annual Meeting

Dec 4, 2024, 4:05 PM EST - 4 months ago

NeuroPace to Showcase the RNS System at the 2024 American Epilepsy Society (AES) Annual Meeting

NeuroPace Completes Enrollment in Feasibility Study of RNS System for Lennox-Gastaut Syndrome

Dec 3, 2024, 4:05 PM EST - 4 months ago

NeuroPace Completes Enrollment in Feasibility Study of RNS System for Lennox-Gastaut Syndrome

NeuroPace, Inc. (NPCE) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 7:59 PM EST - 5 months ago

NeuroPace, Inc. (NPCE) Q3 2024 Earnings Call Transcript

NeuroPace Announces FDA Submission of Three-Year Data from Post-Approval Study of the RNS System in Focal Epilepsy

Nov 4, 2024, 4:05 PM EST - 5 months ago

NeuroPace Announces FDA Submission of Three-Year Data from Post-Approval Study of the RNS System in Focal Epilepsy

NeuroPace to Report Third Quarter 2024 Financial Results on November 12, 2024

Oct 22, 2024, 4:05 PM EDT - 6 months ago

NeuroPace to Report Third Quarter 2024 Financial Results on November 12, 2024

NeuroPace Continues to Strengthen Management Team

Oct 16, 2024, 4:05 PM EDT - 6 months ago

NeuroPace Continues to Strengthen Management Team

NeuroPace Strengthens Management Team with Two Key Appointments

Sep 4, 2024, 4:05 PM EDT - 8 months ago

NeuroPace Strengthens Management Team with Two Key Appointments

NeuroPace Announces Participation at Two Upcoming Healthcare Investor Conferences

Aug 27, 2024, 4:05 PM EDT - 8 months ago

NeuroPace Announces Participation at Two Upcoming Healthcare Investor Conferences

NeuroPace to Participate in Upcoming Healthcare Conferences in September

Aug 22, 2024, 4:05 PM EDT - 8 months ago

NeuroPace to Participate in Upcoming Healthcare Conferences in September

NeuroPace: Only For Those With Strong Nerves

Aug 20, 2024, 1:01 PM EDT - 8 months ago

NeuroPace: Only For Those With Strong Nerves

NeuroPace, Inc. (NPCE) Q2 2024 Earnings Call Transcript

Aug 13, 2024, 10:22 PM EDT - 8 months ago

NeuroPace, Inc. (NPCE) Q2 2024 Earnings Call Transcript

NeuroPace to Report Second Quarter 2024 Financial Results on August 13, 2024

Jul 23, 2024, 4:05 PM EDT - 9 months ago

NeuroPace to Report Second Quarter 2024 Financial Results on August 13, 2024

NeuroPace, Inc. (NPCE) Q1 2024 Earnings Call Transcript

May 12, 2024, 9:08 AM EDT - 1 year ago

NeuroPace, Inc. (NPCE) Q1 2024 Earnings Call Transcript

NeuroPace Reports First Quarter 2024 Financial Results and Provides Corporate Update

May 8, 2024, 4:05 PM EDT - 1 year ago

NeuroPace Reports First Quarter 2024 Financial Results and Provides Corporate Update

NeuroPace to Report First Quarter 2024 Financial Results on May 8, 2024

Apr 17, 2024, 4:05 PM EDT - 1 year ago

NeuroPace to Report First Quarter 2024 Financial Results on May 8, 2024

NeuroPace to Present at the Needham 23rd Annual Healthcare Conference

Mar 27, 2024, 4:05 PM EDT - 1 year ago

NeuroPace to Present at the Needham 23rd Annual Healthcare Conference

NeuroPace, Inc. (NPCE) Q4 2023 Earnings Call Transcript

Mar 5, 2024, 9:29 PM EST - 1 year ago

NeuroPace, Inc. (NPCE) Q4 2023 Earnings Call Transcript

NeuroPace Announces Record Full Year 2023 Revenue of $65.4 Million

Mar 5, 2024, 4:05 PM EST - 1 year ago

NeuroPace Announces Record Full Year 2023 Revenue of $65.4 Million

NeuroPace to Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024

Feb 15, 2024, 4:05 PM EST - 1 year ago

NeuroPace to Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024

NeuroPace Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2023 and Provides Business Updates

Jan 8, 2024, 7:03 AM EST - 1 year ago

NeuroPace Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2023 and Provides Business Updates

NeuroPace Announces Early Completion of Patient Enrollment in NAUTILUS Pivotal Study

Dec 21, 2023, 7:07 AM EST - 1 year ago

NeuroPace Announces Early Completion of Patient Enrollment in NAUTILUS Pivotal Study

NeuroPace to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Dec 19, 2023, 4:30 PM EST - 1 year ago

NeuroPace to Present at the 42nd Annual J.P. Morgan Healthcare Conference

NeuroPace to Leverage the Power of its RNS System's Novel Data Collection, Brain Monitoring and Analysis Capabilities in Groundbreaking Collaboration

Dec 4, 2023, 5:07 PM EST - 1 year ago

NeuroPace to Leverage the Power of its RNS System's Novel Data Collection, Brain Monitoring and Analysis Capabilities in Groundbreaking Collaboration

NeuroPace and the RNS System Showcased at the 77th American Epilepsy Society (AES) Annual Meeting

Dec 1, 2023, 8:00 AM EST - 1 year ago

NeuroPace and the RNS System Showcased at the 77th American Epilepsy Society (AES) Annual Meeting

NeuroPace to Present at the Piper Sandler 35th Annual Healthcare Conference

Nov 21, 2023, 8:00 AM EST - 1 year ago

NeuroPace to Present at the Piper Sandler 35th Annual Healthcare Conference

NeuroPace, Inc. (NPCE) Q3 2023 Earnings Call Transcript

Nov 6, 2023, 9:44 PM EST - 1 year ago

NeuroPace, Inc. (NPCE) Q3 2023 Earnings Call Transcript

NeuroPace Reports Third Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance

Nov 6, 2023, 4:03 PM EST - 1 year ago

NeuroPace Reports Third Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance

NeuroPace Announces RNS System Enhancements Designed to Streamline Care

Oct 17, 2023, 4:05 PM EDT - 1 year ago

NeuroPace Announces RNS System Enhancements Designed to Streamline Care

NeuroPace to Report Third Quarter 2023 Financial Results on November 6, 2023

Oct 16, 2023, 5:01 PM EDT - 1 year ago

NeuroPace to Report Third Quarter 2023 Financial Results on November 6, 2023

NeuroPace to Participate in 2023 Cantor Fitzgerald Global Healthcare Conference

Sep 20, 2023, 4:05 PM EDT - 1 year ago

NeuroPace to Participate in 2023 Cantor Fitzgerald Global Healthcare Conference

NeuroPace: A Speculative Epilepsy Play

Sep 5, 2023, 5:22 AM EDT - 1 year ago

NeuroPace: A Speculative Epilepsy Play